GFRAL and neoplasm: GDF15 plasma level correlates with tumor progression and has been considered as a tumor biomarker.47, 55, 82-86 Functionally, GDF15 is now considered as the main actor of cachexia in cancer signaling through its neuroreceptor GFRAL.